Pharmacologic Treatment of Portal Hypertension.
Clin Liver Dis
; 28(3): 417-435, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-38945635
ABSTRACT
Portal hypertension is the key mechanism driving the transition from compensated to decompensated cirrhosis. In this review, the authors described the pathophysiology of portal hypertension in cirrhosis and the rationale of pharmacologic treatment of portal hypertension. We discussed both etiologic and nonetiologic treatment of portal hypertension and the specific clinical scenarios how nonselective beta-blocker can be used in patients with cirrhosis. Finally, the authors summarized the evidence for emerging alternatives for portal hypertension in patients with cirrhosis.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antagonistas Adrenérgicos beta
/
Hipertensão Portal
/
Cirrose Hepática
Limite:
Humans
Idioma:
En
Revista:
Clin Liver Dis
Ano de publicação:
2024
Tipo de documento:
Article